Djingov Gouginski Kyutchukov & Velichkov has advised the Invenio Partners Fund II SCSP on its EUR 3 million investment in SAT Health.
"The investor has a key role in encouraging and helping companies with strong management teams to realize their full potential," DGKV informed. "The purpose of the investment is to expand the presence of SAT Health on the market with a view of becoming the largest telehealth provider in the region."
SAT Health is a Bulgarian company that specializes in the provision of pharma data and patient care solutions.
The Invenio Partners Fund II is a venture capital fund with a focus on Southeast Europe.
The DGKV team was led by Partner Georgi Tzvetkov and Senior Associate Vlada Tsenova.
